Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1420 of 5804
-
Can mindfulness and diet ease the double burden on black women caregivers?
Disease control OngoingDue to health and wealth disparities, no demographic group is more at risk than African American women for the double jeopardy of stress from caregiving for persons living with dementia (PLWD) and stress associated with hypertension (HTN). This double jeopardy puts those they car…
Phase: NA • Sponsor: Ohio State University • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Text message screening could catch perinatal depression early
Knowledge-focused OngoingThe MATTER project is a digital, community-based perinatal mental health screening and early intervention program implemented in primary care and hospital settings in the Alentejo region, Portugal. The project integrates automated digital screening pathways within the national el…
Sponsor: Universidade Nova de Lisboa • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
New scoring system aims to cut child deaths from malnutrition in chad
Disease control CompletedThe purpose of this study is to evaluate the effect of the Responses to Illness Severity Quantification (RISQ) system implementation on mortality and processes of care in a nutritional program treating children 6 to 59 months of age with acute malnutrition in Ngouri, Chad.
Phase: NA • Sponsor: The Hospital for Sick Children • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could a 30-Year-Old blood vessel drug ease Parkinson's?
Symptom relief OngoingThe aim of this phase Ila trial is to provide evidence on safety, tolerability and symptomatic efficacy of the ROCK-inhibitor Fasudil in patients with early Parkinson's disease (PD). Fasudil has shown neuroprotective and pro-regenerative effects, modulated microglial activity and…
Phase: PHASE2 • Sponsor: Technical University of Munich • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Spinal zap plus breathing drills may boost lung power after paralysis
Symptom relief Recruiting nowRespiratory complications are among the leading causes of death in patients with chronic spinal cord injury (SCI). Our previous work showed that pulmonary function can be improved by using our original respiratory training method. However, the effectiveness of this intervention i…
Phase: NA • Sponsor: University of Louisville • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
New dosing strategy aims to make liver cancer drug easier to tolerate
Disease control OngoingThe present protocol (STRAT-aHCC trial) aims to prospectively evaluate the tolerability, quality of life and efficacy of an alternative regimen of regorafenib in patients with advanced hepatocellular carcinoma (HCC) after progression to first-line. Patients will receive increasin…
Phase: PHASE2 • Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Artificial pancreas may protect hearts in type 1 diabetes
Disease control Recruiting nowThis study will examine the potential cardiovascular effect(s) of artificial pancreas (AP) technology in patients with type 1 diabetes. AP technology is a system of devices that closely mimics the glucose-regulating function of a healthy human pancreas. It includes an insulin pum…
Phase: NA • Sponsor: University of Virginia • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Cuff therapy could boost brain recovery after hemorrhage
Disease control Recruiting nowThe goal of this clinical trial is to examine the effect of limb occlusion therapy (remote ischemic conditioning, RIC) in subjects with aneurysmal subarachnoid hemorrhage. The main question it aims to answer is whether RIC can improve long-term recovery in participants with aneu…
Phase: NA • Sponsor: Aarhus University Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New hope for stomach cancer patients with abdominal spread
Disease control Recruiting nowTo learn about the effects of paclitaxel and gastrectomy (surgery to remove all or part of the stomach) on improving outcomes in patients with gastric cancer.
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Beetroot juice boosts leg circulation in new PAD study
Symptom relief Recruiting nowSupervised exercise therapy (SET), consisting of treadmill exercise conducted three times weekly at a center while supervised by healthcare personnel, is first line therapy for people disabled by lower extremity peripheral artery disease (PAD). However, travelling three times/wee…
Phase: PHASE3 • Sponsor: Northwestern University • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
Could a special diet boost rectal cancer treatment?
Disease control Recruiting nowThis clinical study aims to assess feasibility, safety, tolerability, and compliance of a Nonessential Amino Acid Restriction (NEAAR) medical food in adult patients with locally advanced rectal cancer during standard of care short course radiotherapy followed by standard of care …
Phase: NA • Sponsor: University of South Florida • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New antibody aims to shield kidneys from autoimmune attack
Disease control Recruiting nowThe goal of this clinical trial is to learn if a new drug that might help protect and preserve kidney function in antineutrophil cytoplasmic antibody (ANCA) associated vasculitis (AAV). AAV is a type of autoimmune disease where the body's own immune system attacks itself, and in …
Phase: PHASE2 • Sponsor: Alentis Therapeutics AG • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New pill could reduce Blood-Letting for rare blood cancer patients
Disease control CompletedThis study will evaluate the safety, efficacy, pharmacokinetics (PK), and pharmacodynamics of the orally administered lysine-specific demethylase 1 (LSD1) inhibitor bomedemstat, in participants with polycythemia vera (PV). At Week 36 of dosing, participants will be assessed for e…
Phase: PHASE2 • Sponsor: Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA) • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New injection combo shows promise for Hard-to-Treat cancers
Disease control Recruiting nowBS008-001 is a multicenter, open-label phase Ib /II trial in heavily pre-treated patients with advanced solid tumors. Patients received biweekly sequential intratumoral injections of OH2 (fixed dose: 10⁷ CCID₅₀/mL) followed by BS006 (dose escalation: 10⁶-10⁷ CCID₅₀/mL), with iden…
Phase: PHASE1, PHASE2 • Sponsor: Binhui Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New study aims to curb childhood obesity in food-driven kids
Prevention Recruiting nowHigh food motivation among children is trait-like and increases risks of unhealthy dietary intake and obesity. Scientific knowledge of how parenting can best support healthy eating habits and growth among children who are predisposed to overeating is surprisingly limited. This in…
Phase: NA • Sponsor: Temple University • Aim: Prevention
Last updated Jun 27, 2026 07:56 UTC
-
New hope for tough cancers: experimental drug IMGS-001 enters human trials
Disease control Recruiting nowThe purpose of this Phase 1a/1b clinical trial is to test the safety of an investigational drug called IMGS-001 and to determine how well it can work in treating patients with advanced solid tumors that have come back or are not improving after receiving other drugs that are comm…
Phase: PHASE1 • Sponsor: ImmunoGenesis • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Could a single injection from donated tissue ease knee arthritis pain?
Symptom relief CompletedThis study is being conducted to evaluate the efficacy and safety of ASA compared to placebo in the management of osteoarthritis (OA) symptoms of the knee.
Phase: PHASE3 • Sponsor: Organogenesis • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New drug cocktail targets tough stomach cancer in Last-Resort patients
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy and safety of rivoceranib and paclitaxel combination therapy in patients with P-glycoprotein overexpressing GIST who failed standard treatment with imatinib, sunitinib, and regorafenib.
Phase: PHASE2 • Sponsor: Asan Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Brain zapping shows promise for early Alzheimer's
Symptom relief CompletedThis study aims to investigate the effectiveness and safety of rTMS treatment under the guidance of personalized Brain Functional Sectors (pBFS) for the cognitive ability of patients with mild Alzheimer's disease.
Phase: NA • Sponsor: Changping Laboratory • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
New endoscopic procedure could help fight obesity without surgery
Disease control CompletedThis study is intended to investigate safety and feasibility of a new weight loss technique called endoscopic Gastric Mucosal Ablation (GMA) that does not require surgery, but can be achieved using an endoscopic procedure. Previous studies have suggested that weight loss after v…
Phase: NA • Sponsor: Erbe Elektromedizin GmbH • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC